Fosapreptant

SunGen Pharma receives seventh ANDA approval from US FDA
Pharmaceutical Business Review
Fri, 09/6/19 - 08:30 pm
SunGen Pharma
FDA
Fosapreptant
cyclic vomiting
chemotherapy-induced nausea and vomiting